Clinical and pathological features of combined hepatocellular–cholangiocarcinoma compared with other liver cancersKazuki Wakizaka, Akinobu Taketomi, Koichi Kato et al.|Journal of Gastroenterology and Hepatology|2018Cited by 92
Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinomaMasafumi Ohira, Masaki Mori, Tomoharu Yoshizumi et al.|Surgery Today|2019Cited by 29
Serum fatty acid-binding protein 5 is a significant factor in hepatocellular carcinoma progression independent of tissue expression levelMasafumi Ohira, Akinobu Taketomi|Carcinogenesis|2021Cited by 11